UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
UroGen Pharma Ltd. announced the launch of its LG-UTUC Luminaries initiative which recognizes clinicians and institutions demonstrating leadership in treating low-grade upper tract urothelial cancer (LG-UTUC), a rare and recurrent form of cancer. The program aims to promote kidney-sparing treatment approaches and foster collaboration among urology …